Search

Author/Creator Picus, Joel

1. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. Issue 7 (20th March 2015)

Authors:
Cho, May; Wang‐Gillam, Andrea; Myerson, Robert; Gao, Feng; Strasberg, Steven; Picus, Joel; Sorscher, Steven; Fournier, Chloe; Nagaraj, Gayathri; Parikh, Parag; Suresh, Rama; Linehan, David; Tan, Benjamin R.
Journal:
HPB
Issue:
Volume 17:Issue 7(2015:Jul.)
Page Start:
587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. Issue 7 (July 2015)

Authors:
Cho, May; Wang‐Gillam, Andrea; Myerson, Robert; Gao, Feng; Strasberg, Steven; Picus, Joel; Sorscher, Steven; Fournier, Chloe; Nagaraj, Gayathri; Parikh, Parag; Suresh, Rama; Linehan, David; Tan, Benjamin R.
Journal:
HPB
Issue:
Volume 17:Issue 7(2015:Jul.)
Page Start:
587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database. (February 2019)

Authors:
Fischer-Valuck, Benjamin W.; Michalski, Jeff M.; Contreras, Jessika A.; Brenneman, Randall; Christodouleas, John P.; Abraham, Christopher D.; Kim, Eric H.; Arora, Vivek K.; Bullock, Arnold D.; Carmona, Ruben; Figenshau, Robert S.; Grubb, Robert; Knoche, Eric M.; Pachynski, Russell K.; Picus, Joel...
Journal:
Clinical and translational radiation oncology
Issue:
Volume 15(2019)
Page Start:
38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805. Issue 12 (10th May 2022)

Authors:
Morgans, Alicia K.; Chen, Yu‐Hui; Jarrard, David F.; Carducci, Michael; Liu, Glenn; Eisenberger, Mario; Plimack, Elizabeth R.; Bryce, Alan; Garcia, Jorge A.; Dreicer, Robert; Vogelzang, Nicholas J.; Picus, Joel; Shevrin, Daniel; Hussain, Maha; DiPaola, Robert S.; Cella, David; Sweeney, Christophe...
Journal:
Prostate
Issue:
Volume 82:Issue 12(2022)
Page Start:
1176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update. (May 2018)

Authors:
Choueiri, Toni K.; Hessel, Colin; Halabi, Susan; Sanford, Ben; Michaelson, M. Dror; Hahn, Olwen; Walsh, Meghara; Olencki, Thomas; Picus, Joel; Small, Eric J.; Dakhil, Shaker; Feldman, Darren R.; Mangeshkar, Milan; Scheffold, Christian; George, Daniel; Morris, Michael J.
Journal:
European journal of cancer
Issue:
Volume 94(2018)
Page Start:
115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial. (9th August 2019)

Authors:
George, Daniel J.; Hessel, Colin; Halabi, Susan; Michaelson, M. Dror; Hahn, Olwen; Walsh, Meghara; Picus, Joel; Small, Eric J.; Dakhil, Shaker; Feldman, Darren R.; Mangeshkar, Milan; Scheffold, Christian; Morris, Michael J.; Choueiri, Toni K.
Journal:
Oncologist
Issue:
Volume 24:Number 11(2019)
Page Start:
1497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115–125]. (November 2018)

Authors:
Choueiri, Toni K.; Hessel, Colin; Halabi, Susan; Sanford, Ben; Michaelson, M. Dror; Hahn, Olwen; Walsh, Meghara; Olencki, Thomas; Picus, Joel; Small, Eric J.; Dakhil, Shaker; Feldman, Darren R.; Mangeshkar, Milan; Scheffold, Christian; George, Daniel; Morris, Michael J.
Journal:
European journal of cancer
Issue:
Volume 103(2018)
Page Start:
287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Issue 3 (March 2016)

Authors:
Armstrong, Andrew J; Halabi, Susan; Eisen, Tim; Broderick, Samuel; Stadler, Walter M; Jones, Robert J; Garcia, Jorge A; Vaishampayan, Ulka N; Picus, Joel; Hawkins, Robert E; Hainsworth, John D; Kollmannsberger, Christian K; Logan, Theodore F; Puzanov, Igor; Pickering, Lisa M; Ryan, Christopher W;...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 3(2016:Mar.)
Page Start:
378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes. Issue 4 (20th December 2018)

Authors:
Grivas, Petros; Mortazavi, Amir; Picus, Joel; Hahn, Noah M.; Milowsky, Matthew I.; Hart, Lowell L.; Alva, Ajjai; Bellmunt, Joaquim; Pal, Sumanta K.; Bambury, Richard M.; O'Donnell, Peter H.; Gupta, Sumati; Guancial, Elizabeth A.; Sonpavde, Guru P.; Faltaos, Demiana; Potvin, Diane; Christensen, Ja...
Journal:
Cancer
Issue:
Volume 125:Issue 4(2019)
Page Start:
533
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies. (September 2021)

Authors:
Lim, Kian-Huat; Opyrchal, Mateusz; Acharya, Abhi; Boice, Nick; Wu, Ningying; Gao, Feng; Webster, Jace; Lockhart, Albert C.; Waqar, Saiama N.; Govindan, Ramaswamy; Morgensztern, Daniel; Picus, Joel; Tan, Benjamin R.; Baggstrom, Maria Q.; Maher, Christopher A.; Wang-Gillam, Andrea
Journal:
European journal of cancer
Issue:
Volume 154(2021)
Page Start:
102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗